GlassScriptPhysician profile
Amita Singh
NPI 1437387644
$6,230.14
in general payments reported to CMS, 2019-2025
32 companies · $78.72 in 2025
The $78.72 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,721 · 2020: $648 · 2021: $369 · 2022: $120 · 2023: $102 · 2024: $3,192 · 2025: $78.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $508 · Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $507.84 |
| Food and Beverage | $364.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,132.90 | 2024 | |
| Glaxosmithkline, LLC. | $629.14 | 2019-2025 | Trelegy Ellipta, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $557.15 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $334.86 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $233.18 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $196.27 | 2019-2020 | |
| Genzyme Corporation | $95.94 | 2019-2024 | |
| United Therapeutics Corporation | $93.46 | 2019-2020 | |
| Mylan Specialty L.P. | $89.51 | 2019 | |
| Mallinckrodt Enterprises LLC | $81.21 | 2019 | |
| Abbvie INC. | $81.03 | 2021 | |
| Sunovion Pharmaceuticals INC. | $76.81 | 2019 | |
| Advanced Respiratory, INC | $74.00 | 2019-2021 | |
| Insmed, INC. | $63.18 | 2019-2020 | |
| Shire North American Group INC | $59.73 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $48.04 | 2019 | |
| Medical Device Business Services, INC. | $44.53 | 2023 | Na |
| Regeneron Healthcare Solutions, INC. | $39.26 | 2021-2022 | |
| Ethicon INC. | $36.72 | 2023 | Monarch Platform |
| Philips North America LLC | $32.78 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $28.83 | 2020-2022 | |
| Inspire Medical Systems, INC. | $23.03 | 2024 | Inspire |
| Grifols USA, LLC | $22.95 | 2021 | |
| Resmed Corp | $20.19 | 2020 | |
| Pulmonx Corporation | $19.88 | 2024 | Zephyr Delivery Catheter, Chartis Catheter, Zephyr Endobronchial Valve |
| Amgen INC. | $18.76 | 2022 | |
| Nabriva Therapeutics, Plc | $18.43 | 2021 | |
| Mallinckrodt Hospital Products INC. | $16.89 | 2020 | |
| Becton, Dickinson and Company | $16.65 | 2025 | Hemosphere |
| Teva Pharmaceuticals USA, INC. | $15.69 | 2021 | |
| Jazz Pharmaceuticals INC. | $15.59 | 2019 | |
| Allergan, INC. | $13.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amita Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.